Researchers are continuing to study how hemp-derived cannabinoids interact with cellular stress and inflammation pathways. In the study “Metabolic responses of three distinct melanoma cell lines to UVA radiation and cannabigerol,” scientists examined how cannabigerol (CBG) affected melanoma cells exposed to UVA radiation. The research focused on oxidative stress, inflammation, and metabolic signaling pathways that […]
Category: Cancer
CBG Research Examines Stress Pathways in Pancreatic Cancer Cells (Pub. March 2026)
Researchers continue exploring how hemp-derived cannabinoids may interact with cellular stress and inflammatory pathways involved in disease progression. In the study “Cannabigerol induces endoplasmic reticulum stress-mediated apoptosis and ferroptosis via the IRE1α-XBP1 axis in human pancreatic cancer cells,” scientists investigated how cannabigerol (CBG) affected human pancreatic cancer cells in laboratory models. The findings showed that […]
Cannabidiol (CBD) Shows Antitumor Activity in Melanoma Through Gene-Regulation Mechanisms (pub. Feb 2026)
Melanoma is one of the most aggressive forms of skin cancer, largely due to its ability to grow rapidly and spread to other parts of the body. In this study, researchers investigated how cannabidiol (CBD) affects melanoma progression by examining its influence on gene-regulation pathways involved in cancer cell survival and metastasis. Using laboratory experiments […]